Investments (Tables)

12 Months Ended

Dec. 31, 2023

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Investments in Unconsolidated Ventures

The Company's equity and debt investments are represented by the following:

(In thousands)	December 31, 2023		December 31, 2022
Equity method investments (1)
Principal investments	$	1,194,417	$	410,511
Carried interest allocation	676,421		341,749
Other equity investments	71,417		115,024
CLO subordinated notes	50,927		50,927
Loans receivable	—		133,307
	1,993,182		1,051,518
Equity investments of consolidated funds
Marketable equity securities	66,297		139,076
Other investments	416,614		46,769
	$	2,476,093	$	1,237,363

__________

(1)    Equity method investments in the Investment Management segment are $726.1 million at December 31, 2023 and $393.4 million at December 31, 2022..

Schedule of Available-for-sale Securities

The balance of the CLO subordinated notes is summarized as follows:

	Amortized Cost without Allowance for Credit Loss		Allowance for Credit Loss		Gross Cumulative Unrealized
(in thousands)					Gains		Losses		Fair Value
At December 31, 2023 and 2022	$	50,927	$	—	$	—	$	—	$	50,927

Schedule of Equity Method Investments

The following tables present selected combined financial information of the Company's equity method investees, excluding investees classified as discontinued operations. Amounts presented represent combined totals at the investee level and not the Company's proportionate share.

Selected Combined Balance Sheet Information

(In thousands)	December 31, 2023		December 31, 2022
Total assets	$	38,062,830	$	22,507,463
Total liabilities	413,270		79,053
Owners' equity	37,649,560		22,428,410

Selected Combined Statements of Operations Information

	Year Ended December 31,
(In thousands)	2023		2022		2021
Total revenues	$	117,846	$	23,232	$	39,760
Net income (loss)	2,976,972		2,150,989		771,962